浩欧博股价涨5.59%，招商基金旗下1只基金重仓，持有1.13万股浮盈赚取9.79万元

Group 1 - The core point of the news is that Jiangsu Haobo Bio-Pharmaceutical Co., Ltd. experienced a stock price increase of 5.59%, reaching 163.99 CNY per share, with a total market capitalization of 10.41 billion CNY as of October 20 [1] - The company, established on June 8, 2009, and listed on January 13, 2021, specializes in the research, production, and sales of in vitro diagnostic reagents [1] - The revenue composition of the company includes 89.46% from reagent sales, 5.86% from other sales, 3.84% from instrument sales, and 0.85% from leasing sales [1] Group 2 - From the perspective of fund holdings, one fund under China Merchants Fund has a significant position in Haobo Bio, with the China Merchants Growth Pioneer Stock A (014589) holding 11,300 shares, unchanged from the previous period, accounting for 4.54% of the fund's net value [2] - The fund has a total size of 29.46 million CNY and has achieved a year-to-date return of 32.34%, ranking 1195 out of 4218 in its category [2] - The fund manager, Mei Mei, has been in position for 270 days, with the best return during this period being 38.04% and the worst being -0.97% [2]